Primary Clinical Indications
The main therapeutic application of benzodiazepines is the treatment of sleep disorders of various etiologies. Physicians prescribe these drugs for insomnia triggered by acute stress, severe anxiety, or significant jet lag. Agents in this group effectively manage various types of sleep disturbances: they help patients struggling with sleep onset (initial insomnia), those suffering from frequent nocturnal awakenings (middle insomnia), or those waking up too early in the morning (terminal insomnia).
A second major area of use is anesthesiology. In surgical practice, benzodiazepines are routinely administered during the premedication phase to prepare the patient's nervous system for an upcoming surgical procedure.
Classification by Duration of Effect
Although drugs can be categorized by chemical structure, routes of administration, and mechanism of action, the classification based on duration of therapeutic effect is most clinically relevant. Three main groups are distinguished:
- Long-acting: A typical representative of this category is flunitrazepam.
- Intermediate-acting: This group includes nitrazepam.
- Short-acting: Ultra-short and short-acting profiles, such as triazolam and midazolam.
Drugs from the first two groups can maintain continuous sleep lasting 6 to 8 hours. A pharmacokinetic feature of certain prolonged-action drugs (e.g., diazepam and flurazepam) is that their extended duration of action is mediated by biotransformation in the body into active metabolites.
Adverse Effects and Limitations
Benzodiazepine therapy is associated with several specific side effects. The most common is the hangover effect, which is particularly pronounced with long-acting drugs. It manifests the day after evening administration. Patients may complain of daytime drowsiness, generalized lethargy, and significantly slowed psychomotor reactions.
Due to this effect, strict occupational limitations are imposed: benzodiazepines are contraindicated for individuals whose work requires constant attention and high reaction speeds, primarily motor vehicle operators and handlers of complex machinery.
Complications of Long-Term Use
Chronic use of hypnotics in this group requires strict medical supervision, as it is associated with several dangerous phenomena:
- Accumulation: With regular intake, active substances (especially long-acting ones) can accumulate in the body.
- Tolerance (Habituation): Over time, receptors lose sensitivity to the drug, requiring the patient to increase the dose to achieve the initial hypnotic effect.
- Drug Dependence: Both psychological and physical dependence can develop with prolonged use.
- Rebound Effect: A specific reaction occurring upon abrupt cessation (more characteristic of short-acting agents). It manifests as insomnia returning in an even more severe form. Therefore, tapering therapy must be done very smoothly and gradually.
Comparative Characteristics with Barbiturates
Although benzodiazepines are inferior to barbiturates in absolute hypnotic potency, they are currently recognized as the drugs of choice. This is due to numerous advantages:
- High Safety: They possess a significantly wider therapeutic index, minimizing the risk of fatal outcome in acute overdose.
- Sleep Quality: Drugs in this group disrupt the physiological phase structure of sleep to a much lesser extent.
- Reduced Drug Interactions: Benzodiazepines cause less pronounced induction of hepatic microsomal enzymes.
- Lower Abuse Potential: Tolerance and dependence develop much more slowly. In addition, the overall incidence of side effects is lower, and the withdrawal syndrome inevitable with physical dependence is less distressing than that seen with barbiturate discontinuation.